Cancer has become a burgeoning global healthcare concern marked by its exponential
growth and significant economic ramifications. Though advancements in the treatment …

Gastric cancer (GC) is the fourth leading cause of death worldwide, with more than 1 million
cases diagnosed every year. Helicobacter pylori represents the main risk factor, being …

Background Minimally invasive total gastrectomy (MITG) is a mainstay for curative treatment
of patients with gastric cancer. To define and standardize optimal surgical techniques and …

Background Gastric cancer (GC) poses a global health challenge due to its widespread
prevalence and unfavorable prognosis. Although immunotherapy has shown promise in …

In the current study, Neosetophomone B (NSP–B) was investigated for its anti-cancerous
potential using network pharmacology, quantum polarized ligand docking, molecular …

Simple Summary ARID1A mutations are emerging as a prognostic and predictive factor in
gastric cancer. Recent studies suggest their potential role in predicting patient response to …

Accurate prediction of gastric cancer patient survival time is essential for clinical decision-
making. However, unified static models lack specificity and flexibility in predictions owing to …

Aims Cellular senescence (CS) represents an intracellular defense mechanism responding
to stress signals and can be leveraged as a “vulnerability” in cancer treatment. This study …

This study aimed to investigate the potential of beef peptides (BPs) in mitigating muscle
atrophy induced by dexamethasone (DEX) with underlying three mechanisms in vitro …

Oxaliplatin (OXA) is recognized as a first-line drug for gastric cancer. However, low
accumulation of the OXA in the target site and the development of drug resistance directly …